Oncology and Hematology

Episodes 273-288 of 463

Insights from global key opinion leaders on optimizing patient care in NSCLC
Insights from global key opinion leaders on optimizing patient care in NSCLC
MinuteCE®
Insights from global key opinion leaders on optimizing patient care in NSCLC
1.00 program credit
- Luis Paz-Ares, MD, PhD
- Helena Yu, MD
- Matthew Gubens, MD, MS
1.00 program credit
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Clinician's Roundtable
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Project Oncology®
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah McManus, MD
- Andrew Armstrong, MD, MSc
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
Project Oncology®
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
CME/CE
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
0.25 credits
- Joyce O'Shaughnessy, MD
0.25 credits
How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
Project Oncology®
How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
- Daniel Kwon, MD
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Project Oncology®
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
- Betsy O'Donnell, MD
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
- David Braun
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
- Hannah Lee, MD
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
- David Braun, MD, PhD
Enhancing HCC Outcomes Through Multidisciplinary Care
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Lee, MD
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
- Munir Ghesani, MD
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Project Oncology®
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
- Robert Wong, MD